Nancy Reau

3.8k total citations
110 papers, 1.4k citations indexed

About

Nancy Reau is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Nancy Reau has authored 110 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Hepatology, 78 papers in Epidemiology and 16 papers in Infectious Diseases. Recurrent topics in Nancy Reau's work include Liver Disease Diagnosis and Treatment (67 papers), Hepatitis C virus research (62 papers) and Hepatitis B Virus Studies (41 papers). Nancy Reau is often cited by papers focused on Liver Disease Diagnosis and Treatment (67 papers), Hepatitis C virus research (62 papers) and Hepatitis B Virus Studies (41 papers). Nancy Reau collaborates with scholars based in United States, Germany and France. Nancy Reau's co-authors include Joseph Ahn, Tram T. Tran, Dorte Møller Jensen, Donald M. Jensen, Tatyana Kushner, Andrew Aronsohn, Helen S. Te, Natasha K. Martin, Michael Fried and Archita P. Desai and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Nancy Reau

103 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nancy Reau United States 20 994 916 185 178 103 110 1.4k
Ajeet Singh Bhadoria India 21 602 0.6× 591 0.6× 340 1.8× 54 0.3× 63 0.6× 127 1.4k
Ponni Perumalswami United States 20 861 0.9× 903 1.0× 74 0.4× 209 1.2× 61 0.6× 86 1.2k
Ziv Ben Ari Israel 16 893 0.9× 806 0.9× 201 1.1× 245 1.4× 46 0.4× 38 1.3k
Regino P. González‐Peralta United States 29 1.9k 1.9× 1.7k 1.9× 294 1.6× 169 0.9× 60 0.6× 90 2.5k
Vandana Khungar United States 15 527 0.5× 577 0.6× 213 1.2× 45 0.3× 72 0.7× 35 889
Biyao Zou United States 16 627 0.6× 1.3k 1.4× 233 1.3× 298 1.7× 54 0.5× 27 2.0k
Mithun Sharma India 21 506 0.5× 654 0.7× 361 2.0× 324 1.8× 19 0.2× 90 1.2k
Akash Shukla India 16 449 0.5× 390 0.4× 373 2.0× 88 0.5× 41 0.4× 107 874
Sonal Kumar United States 19 408 0.4× 528 0.6× 244 1.3× 209 1.2× 34 0.3× 71 956
Silvia Martini Italy 21 1.0k 1.0× 1.0k 1.1× 568 3.1× 120 0.7× 68 0.7× 54 1.5k

Countries citing papers authored by Nancy Reau

Since Specialization
Citations

This map shows the geographic impact of Nancy Reau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Reau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Reau more than expected).

Fields of papers citing papers by Nancy Reau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Reau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Reau. The network helps show where Nancy Reau may publish in the future.

Co-authorship network of co-authors of Nancy Reau

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Reau. A scholar is included among the top collaborators of Nancy Reau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Reau. Nancy Reau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sanyal, Arun J., Kris V. Kowdley, Nancy Reau, et al.. (2024). Rifaximin plus lactulose versus lactulose alone for reducing the risk of HE recurrence. Hepatology Communications. 8(6). 6 indexed citations
2.
Reau, Nancy, Craig Lammert, & Ethan M. Weinberg. (2024). Autoimmune hepatitis: Current and future therapies. Hepatology Communications. 8(6). 14 indexed citations
3.
4.
Malhi, Harmeet, Robert S. Brown, Joseph K. Lim, et al.. (2023). Precipitous changes in nomenclature and definitions—NAFLD becomes SLD: Implications for and expectations of AASLD journals. Liver Transplantation. 29(12). 1262–1263. 2 indexed citations
5.
Malhi, Harmeet, Robert S. Brown, Joseph K. Lim, et al.. (2023). Precipitous changes in nomenclature and definitions—NAFLD becomes SLD: Implications for and expectations of AASLD journals. Clinical Liver Disease. 22(6). 193–194. 1 indexed citations
6.
Brown, Robert S., et al.. (2023). Improving the Management of Hepatorenal Syndrome-Acute Kidney Injury Using an Updated Guidance and a New Treatment Paradigm.. PubMed. 19(9). 527–536. 2 indexed citations
7.
Malhi, Harmeet, Robert S. Brown, Joseph K. Lim, et al.. (2023). Precipitous changes in nomenclature and definitions—NAFLD becomes SLD: Implications for and expectations of AASLD journals. Hepatology Communications. 7(11). 2 indexed citations
8.
Malhi, Harmeet, Robert S. Brown, Joseph K. Lim, et al.. (2023). Precipitous changes in nomenclature and definitions—NAFLD becomes SLD: Implications for and expectations of AASLD journals. Hepatology. 78(6). 1680–1681. 8 indexed citations
9.
Jung, Jae Hyung, et al.. (2023). Use of tecovirimat for mpox infection followed by JYNNEOS vaccination postinfection in a liver transplant recipient. Transplant Infectious Disease. 25(3). e14030–e14030. 2 indexed citations
10.
Ratziu, Vlad, Quentin M. Anstee, Vincent Wai‐Sun Wong, et al.. (2022). An international survey on patterns of practice in NAFLD and expectations for therapies—The POP‐NEXT project. Hepatology. 76(6). 1766–1777. 8 indexed citations
11.
Serper, Marina, Donna M. Evon, Paul W. Stewart, et al.. (2021). Patient‐reported outcomes 12 months after hepatitis C treatment with direct‐acting antivirals: Results from the PROP UP study. Liver International. 41(4). 692–704. 7 indexed citations
12.
Kushner, Tatyana & Nancy Reau. (2020). Changing epidemiology, implications, and recommendations for hepatitis C in women of childbearing age and during pregnancy. Journal of Hepatology. 74(3). 734–741. 33 indexed citations
13.
Chaillon, Antoine, Adriane Wynn, Tatyana Kushner, Nancy Reau, & Natasha K. Martin. (2020). Cost-effectiveness of Antenatal Rescreening Among Pregnant Women for Hepatitis C in the United States. Clinical Infectious Diseases. 73(9). e3355–e3357. 12 indexed citations
14.
Do, Albert & Nancy Reau. (2020). Chronic Viral Hepatitis: Current Management and Future Directions. Hepatology Communications. 4(3). 329–341. 27 indexed citations
15.
16.
Evon, Donna M., Carol E. Golin, Paul W. Stewart, et al.. (2017). Patient engagement and study design of PROP UP: A multi-site patient-centered prospective observational study of patients undergoing hepatitis C treatment. Contemporary Clinical Trials. 57. 58–68. 12 indexed citations
17.
Sise, Meghan E., Naim Alkhouri, Brian B. Borg, et al.. (2017). Use of ledipasvir/sofosbuvir in patients with advanced chronic kidney disease (eGFR ≤ 30 mL/min): a case series. Journal of Hepatology. 66(1). S721–S722. 1 indexed citations
18.
19.
Te, Helen S., Dingcai Cao, Rohit Satoskar, et al.. (2012). Use of immune function test in monitoring immunosuppression in liver transplant recipients. Clinical Transplantation. 26(6). 826–832. 9 indexed citations
20.
Gaetano, John N. & Nancy Reau. (2012). Hepatitis C: Management of Side Effects in the Era of Direct-Acting Antivirals. Current Gastroenterology Reports. 15(1). 305–305. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ajeet Singh Bhadoria Breakdown of academic impact, for papers by Ponni Perumalswami Breakdown of academic impact, for papers by Ziv Ben Ari Breakdown of academic impact, for papers by Regino P. González‐Peralta Breakdown of academic impact, for papers by Vandana Khungar Breakdown of academic impact, for papers by Biyao Zou Breakdown of academic impact, for papers by Mithun Sharma Breakdown of academic impact, for papers by Akash Shukla Breakdown of academic impact, for papers by Sonal Kumar Breakdown of academic impact, for papers by Silvia Martini
Rankless by CCL
2026